DHL has published a white paper on delivering stable logistics for vaccines and medical goods during COVID-19 and future health crises. [ + ]

Opyl has developed software that uses artificial intelligence to predict the probability of a vaccine, drug, diagnostic or medical device succeeding in clinical trials. [ + ]

US researchers aimed to determine whether a 28-day period of disrupted sleep changed the gut microbiota in rats. [ + ]

Researchers have found that the SMOC1 protein, which is naturally produced by the liver, can decrease blood glucose levels. [ + ]

A prototype medical imaging device can produce images down to resolutions of 1 to 2 µm — detailed enough to spot the first signs of tumours in specific cells. [ + ]

The COVID-19 vaccine trial, which has produced positive indications about its potential effectiveness and manufacturability, is being expanded to an older demographic. [ + ]

Korean researchers have developed a nano-filter that maintains excellent filtering efficiency, even after handwashing. [ + ]

An international research team has suggested that the possibility of high-risk drinkers developing alcohol-induced cirrhosis is in part related to genetic factors. [ + ]

A recent study found that the composition, quantity and dominant bacteria of the tongue coating differ between heart failure patients and healthy people. [ + ]

Researchers have identified mechanisms leading to the functional deterioration of the immune system in response to severe viral infections, such as HIV or COVID-19. [ + ]

The company has been launched in Queensland to help accelerate the development and commercialisation of Australian-born medical devices for the global market. [ + ]

Anyone in the world with a PC, Mac or laptop with an internet connection can help scientists seek chemical compounds that might be effective against COVID-19. [ + ]

Intravacc has published the phase I study results of its vaccine candidate for respiratory syncytial virus — a major cause of lower respiratory tract infections. [ + ]

Launched by CSIRO and accredited by NATA, the new facility has the capacity to provide a rapid turnaround on surgical face mask testing. [ + ]

The drugs work through a mechanism that is distinct from currently prescribed medicines for asthma and chronic obstructive pulmonary disease. [ + ]